These emerging treatments, Retatrutide, represent a groundbreaking advancement in addressing type 2 diabetes and potentially related conditions . These drugs are grouped as GLP-1 hormone activators , indicating these substances to mimic the body's GLP-1 hormone , boosting glucose release and redu